These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11532857

  • 1. Dietary N-acetyl-L-cysteine modulates benzo[a]pyrene-induced skin tumors in cancer-prone p53 haploinsufficient Tg.AC (v-Ha-ras) mice.
    Martin KR, Trempus C, Saulnier M, Kari FW, Barrett JC, French JE.
    Carcinogenesis; 2001 Sep; 22(9):1373-8. PubMed ID: 11532857
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM, Spalding JW, Tennant RW, Smart RC.
    Cancer Res; 1995 Jul 15; 55(14):3171-8. PubMed ID: 7606738
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of benzo(a)pyrene-induced lung tumorigenesis in A/J mice by dietary N-acetylcysteine conjugates of benzyl and phenethyl isothiocyanates during the postinitiation phase is associated with activation of mitogen-activated protein kinases and p53 activity and induction of apoptosis.
    Yang YM, Conaway CC, Chiao JW, Wang CX, Amin S, Whysner J, Dai W, Reinhardt J, Chung FL.
    Cancer Res; 2002 Jan 01; 62(1):2-7. PubMed ID: 11782348
    [Abstract] [Full Text] [Related]

  • 8. Positive immunohistochemical staining of p53 and cyclin D in advanced mouse skin tumors, but not in precancerous lesions produced by benzo[a]pyrene.
    Mitsunaga SI, Zhang SY, Ruggeri BA, Gimenez-Conti I, Robles AI, Conti CJ, Klein-Szanto AJ.
    Carcinogenesis; 1995 Jul 01; 16(7):1629-35. PubMed ID: 7542177
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tumor spectrum in the p53 heterozygous zeta globin-promoted Tg.AC (v-Ha-ras) bitransgenic mouse model.
    Martin KR, Jokinen MP, Honeycutt HP, Quinn A, Kari FW, Barrett JC, French JE.
    Toxicol Pathol; 2004 Jul 01; 32(4):418-25. PubMed ID: 15204965
    [Abstract] [Full Text] [Related]

  • 12. Ras transgene expression in TG-AC mice treated with benzo[a]pyrene.
    Lee BM, Kim HS, Kim IS, Ahn MY, Chun SA, Yoo SD, Park YA, Choi SM, Kim KB, Han SY, Park KL, Kwack SJ, Song HS, Lee KR, Bae HJ, Cho MH.
    Biol Pharm Bull; 2003 May 01; 26(5):733-5. PubMed ID: 12736523
    [Abstract] [Full Text] [Related]

  • 13. Chemopreventive effect of difluoromethylornithine (DFMO) on mouse skin squamous cell carcinomas induced by benzo(a)pyrene.
    Mitsunaga S, Clapper M, Litwin S, Watts P, Bauer B, Klein-Szanto AJ.
    J Cell Biochem Suppl; 1997 May 01; 28-29():81-9. PubMed ID: 9589352
    [Abstract] [Full Text] [Related]

  • 14. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW, Sarraj S, Lin SC, Tsai PI, Solt D.
    Carcinogenesis; 2000 Jul 01; 21(7):1441-51. PubMed ID: 10874024
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Combined oral carcinogenicity of HPV-16 and benzo(a)pyrene: an in vitro multistep carcinogenesis model.
    Park NH, Gujuluva CN, Baek JH, Cherrick HM, Shin KH, Min BM.
    Oncogene; 1995 Jun 01; 10(11):2145-53. PubMed ID: 7784058
    [Abstract] [Full Text] [Related]

  • 17. Inducible nitric oxide synthase mRNA is upregulated in skin tumors of v-ha-ras transgenic TG-AC mice treated with 12-o-tetradecanoylphorbol-13-acetate.
    Lee BM, Kim HS, Jeohn GH.
    Biol Pharm Bull; 2000 Jul 01; 23(7):826-9. PubMed ID: 10919360
    [Abstract] [Full Text] [Related]

  • 18. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA, Wang XJ, Donehower LA, Roop DR.
    Cancer Res; 1996 Oct 01; 56(19):4413-23. PubMed ID: 8813135
    [Abstract] [Full Text] [Related]

  • 19. Association of tumor development with increased cellular proliferation and transgene overexpression, but not c-Ha-ras mutations, in v-Ha-ras transgenic Tg.AC mice.
    Hansen LA, Trempus CS, Mahler JF, Tennant RW.
    Carcinogenesis; 1996 Sep 01; 17(9):1825-33. PubMed ID: 8824502
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.